Anzeige
Mehr »
Dienstag, 23.12.2025 - Börsentäglich über 12.000 News
Breaking News: "Königs-Exosomen" senken Entzündungslevel um 90%…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12CU5 | ISIN: KYG5438W1116 | Ticker-Symbol: L1PA
Frankfurt
22.12.25 | 08:59
0,164 Euro
-2,38 % -0,004
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
LEES PHARMACEUTICAL HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
LEES PHARMACEUTICAL HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,1700,19922.12.

Aktuelle News zur LEES PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoLEE'S PHARM (00950): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION - ACQUISITION OF ASSETS5
DoLEE'S PHARM (00950): PASSING AWAY OF MICHELE DALLA LIBERA1
11.12.Lee's Pharmaceutical Holdings Limited: Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights330Acquisition of Staccato One Breath Technology, a proprietary platform technology with broad therapeutic potentialSynergistic and complementary to Lee's Pharm's existing products pipeline...
► Artikel lesen
11.12.Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights161Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential Synergistic and complementary to Lee's Pharm's existing products...
► Artikel lesen
08.12.LEE'S PHARM (00950): DISCLOSEABLE TRANSACTION - ACQUISITION OF ASSETS1
15.10.LEE'S PHARM (00950): GRANT OF SHARE OPTIONS2
19.09.LEE'S PHARM (00950): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT-
19.09.LEE'S PHARM (00950): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT1
LEES PHARMACEUTICAL Aktie jetzt für 0€ handeln
19.09.LEE'S PHARM (00950): INTERIM REPORT 20251
12.09.Dividendenbekanntmachungen (12.09.2025)12.314 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ABSA GROUP LIMITED ADR  US00400T1025  0,887 USD  0,7558 EUR  ACADIAN ASSET MANAGEMENT INC  US10948W1036  0,01 USD  0,0085 EUR  ALBEMARLE...
► Artikel lesen
29.08.LEE'S PHARM (00950): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE-
26.08.LEE'S PHARM (00950): INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2025-
26.08.LEE'S PHARM (00950): INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025-
14.08.LEE'S PHARM (00950): NOTICE OF BOARD MEETING2
31.07.LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - UPDATE ON AN INVESTIGATIONAL ONCOLOGY DRUG PRODUCT2
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1